MSB 2.19% 93.5¢ mesoblast limited

Cell Therapy News/Articles, page-13512

  1. 3,949 Posts.
    lightbulb Created with Sketch. 1351
    I don't think @dachopper is wrong, if anything it could take longer. This is why the FDA have the accelerated approval pathway. It gives access to the therapy for those that are most likely to respond and have very much a unmet medical need.

    By my understanding of the process we should find out before the end of this month.

    Good luck all.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
93.5¢
Change
0.020(2.19%)
Mkt cap ! $1.067B
Open High Low Value Volume
92.0¢ 94.5¢ 92.0¢ $1.622M 1.742M

Buyers (Bids)

No. Vol. Price($)
4 64563 93.0¢
 

Sellers (Offers)

Price($) Vol. No.
94.0¢ 204239 3
View Market Depth
Last trade - 16.10pm 11/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.